1999•Leukemia ResearchRequires access

Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine

Pia Raanani, Ofer Shpilberg, Shmuel Gillis, Abraham Avigdor, Izhar Hardan, Miriam Berkowicz, Orit Sofer, Izidore S. Lossos, Angela Chetrit, Dina Ben‐Yehuda, Isaac Ben‐Bassat

Open publisher page 15 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Mitoxantrone, Cytarabine, Medicine, Refractory (planetary science), Salvage therapy, Leukemia, Internal medicine, Regimen

Back to paper search Browse research topics Original source

Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine — Research Paper | ScholarLens